Charles Decarlo, MD
Vascular Surgery · Bronx, NYNPI 1578912887
Payments from drug & device makers
Across 130 payments — averaging $81.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cook Medical LLC$3K
- W. L. Gore & Associates, Inc.$1K
- Boston Scientific$1K
- Medtronic$954
- Penumbra, Inc.$784
- Cagent Vascular Inc$610
- plus $3K from 18 others
What the payments were for
- Consulting fees$4805%
- Food & beverage$9,47789%
- Education$6626%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cook Medical LLC | 34 | $2,525 |
| W. L. Gore & Associates, Inc. | 11 | $1,427 |
| Boston Scientific | 13 | $1,257 |
| Medtronic(2 entities) | 9 | $954 |
| Penumbra, Inc. | 21 | $784 |
| Cagent Vascular Inc | 2 | $610 |
| Surmodics, Inc. | 4 | $503 |
| Silk Road Medical, Inc. | 6 | $497 |
| Endologix LLC | 5 | $473 |
| Inari Medical, Inc. | 6 | $418 |
| Cvrx, Inc. | 1 | $256 |
| Cardiovascular Systems Inc. | 2 | $245 |
| Philips North America LLC | 1 | $118 |
| Shockwave Medical, Inc | 1 | $112 |
| Octapharma USA, Inc. | 3 | $94 |
| Haemonetics Corporation | 1 | $68 |
| Solventum Corporation | 2 | $63 |
| Bolton Medical Inc | 2 | $48 |
| Argon Medical Devices, Inc. | 1 | $45 |
| Limflow Inc. | 1 | $34 |
| Imperative Care, Inc | 1 | $28 |
| Johnson & Johnson | 1 | $26 |
| Cordis US CORP. | 1 | $22 |
| Smith+Nephew | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GORE TAG Conformable Thoracic Endoprosthesis$846
- 2CM PERIPHERAL CUTTING BALLOON$729
- Zenith Spiral-Z$699
- Serrantor$610
- ENROUTE Transcarotid Neuroprotection System$486
- ENROUTE Transcarotid Stent$332
- FLOWTRIEVER CATHETER, S$307
- CT THROMBECTOMY SYSTEM KIT$307
- Cook$268
- Barostim Neo System$256
- Penumbra System$252
- Zenith Alpha$244
- CHOCOLATE PTA BALLOON CATHETER$208
- C3 Delivery System$194
- Pounce LP Thrombectomy$191
- GORE VIABAHN Endoprosthesis with Heparin$172
- ELUVIA$165
- GENERAL CATHETERS$155
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$154
- GORE EXCLUDER Iliac Branch Endoprosthesis$151
How this compares
$10,619 in reported general payments places this provider in the 65th percentile of 405 vascular surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 27 | $16,240 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Bronx
- Edvard SkripochnikBronx$405K
- Evan LipsitzBronx$136K
- Saadat ShariffBronx$69K
- Gary GelbfishNew York$1.9M
- Sundaram RavikumarDobbs Ferry$1.8M
- Antonios GasparisHuntington$1.7M
- John LantisNew York$1.4M
- Sonya NoorBuffalo$1.2M
- Brian DerubertisNew York$1M
- Thomas MaldonadoNew York$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.